Cargando…

Cost-Effectiveness of a Community Pharmacist-Led Sleep Apnea Screening Program – A Markov Model

BACKGROUND: Despite the high prevalence and major public health ramifications, obstructive sleep apnea syndrome (OSAS) remains underdiagnosed. In many developed countries, because community pharmacists (CP) are easily accessible, they have been developing additional clinical services that integrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perraudin, Clémence, Le Vaillant, Marc, Pelletier-Fleury, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689751/ https://www.ncbi.nlm.nih.gov/pubmed/23805176 http://dx.doi.org/10.1371/journal.pone.0063894

Ejemplares similares

Socio-Economic Status: A Barrier to Access to Mandibular Advancement Device Therapy for Patients with Obstructive Sleep Apnea Syndrome in France
por: Fleury, Marion, et al.
Publicado: (2015)

The future of pharmaceutical care in France: a survey of final-year pharmacy students' opinions
por: Perraudin, Clémence, et al.
Publicado: (2011)

British residents’ views about general practice care in France – a telephone survey
por: Pelletier-Fleury, Nathalie, et al.
Publicado: (2013)

Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study
por: Rosman, Sophia, et al.
Publicado: (2011)

Adaptation and validation of the patient assessment of chronic illness care in the French context
por: Krucien, Nicolas, et al.
Publicado: (2014)

Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?
por: Perraudin, Clemence, et al.
Publicado: (2019)

The effects of obesity and mobility disability in access to breast and cervical cancer screening in France: results from the National Health and Disability Survey
por: Bussière, Clémence, et al.
Publicado: (2014)

The Effects of Obesity and Mobility Disability in Access to Breast and Cervical Cancer Screening in France: Results from the National Health and Disability Survey
por: Bussière, Clémence, et al.
Publicado: (2014)

Impact of an educational program on community pharmacist’s preparedness to conduct pharmacist-led diabetes clinic in Saudi Arabia
por: Rasheed, Muhammad Kamran, et al.
Publicado: (2023)

Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care
por: Dineen-Griffin, Sarah, et al.
Publicado: (2020)

998. Challenging Penicillin Allergies: Pharmacist led program in a community hospital
por: Patel, Radha, et al.
Publicado: (2019)

Pharmacist-led minor ailment programs: a Canadian perspective
por: Taylor, Jeff Gordon, et al.
Publicado: (2016)

Pharmacist-led antimicrobial stewardship program in an urgent care setting
por: Fay, Lauren N, et al.
Publicado: (2019)

Pharmacist-led screening in sexually transmitted infections: current perspectives
por: Wood, Helen, et al.
Publicado: (2018)

Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost
por: Maeng, Daniel D, et al.
Publicado: (2018)

Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre
por: Pelletier, Ryan
Publicado: (2021)

Cumulative Association of Obstructive Sleep Apnea Severity and Short Sleep Duration with the Risk for Hypertension
por: Priou, Pascaline, et al.
Publicado: (2014)

Cost Effective Community Based Dementia Screening: A Markov Model Simulation
por: Saito, Erin, et al.
Publicado: (2014)

Identifying Opportunities for Impact of Community-Based Pharmacist-Led Biometric Health Screenings on ASCVD Risk
por: Newell, Bradley J., et al.
Publicado: (2023)

Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program
por: Perlman, Amichai, et al.
Publicado: (2019)

Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
por: Elkomos, Mary, et al.
Publicado: (2022)

A Nurse‐Led Limited Risk Factor Modification Program to Address Obesity and Obstructive Sleep Apnea in Atrial Fibrillation Patients
por: Yaeger, Amaryah, et al.
Publicado: (2018)

Implementation and Effectiveness of an Interprofessional Support Program for Patients with Type 2 Diabetes in Swiss Primary Care: A Study Protocol
por: Bawab, Noura, et al.
Publicado: (2020)

Patients’ with obstructive sleep apnoea syndrome (OSAS) preferences and demand for treatment: a discrete choice experiment
por: Krucien, Nicolas, et al.
Publicado: (2013)

Risk Factors for Sleepiness at the Wheel and Sleep-Related Car Accidents Among Patients with Obstructive Sleep Apnea: Data from the French Pays de la Loire Sleep Cohort
por: Sabil, AbdelKebir, et al.
Publicado: (2021)

The impact of community–pharmacist-led medication reconciliation process: Pharmacist-patient-centered medication reconciliation
por: AlAhmad, Mohammad M, et al.
Publicado: (2020)

Independent Association Between Obstructive Sleep Apnea Severity and Glycated Hemoglobin in Adults Without Diabetes
por: Priou, Pascaline, et al.
Publicado: (2012)

Pilot testing of a pharmacist led care program for asthma patients in Saudi Arabia
por: Meshal, Alotaby, et al.
Publicado: (2015)

A Systematic Review of Pharmacist-Led Antimicrobial Stewardship Programs in Sub-Saharan Africa
por: Otieno, Phanice Ajore, et al.
Publicado: (2022)

Home-based subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy patients: A Swiss cost-minimization analysis
por: Perraudin, Clémence, et al.
Publicado: (2020)

Pharmacotherapy of Obstructive Sleep Apnea: Is Salvation Just Around a Corner?
por: Fleury Curado, Thomaz, et al.
Publicado: (2019)

Implementation of a Student Pharmacist-Led Program to Enhance Health Access in an Arab-American Community Head: Health Program in an Arab-American Community
por: Arif, Sally A., et al.
Publicado: (2023)

Effectiveness of an Interprofessional Program (Siscare) for Supporting Patients With Type 2 Diabetes
por: Bawab, Noura, et al.
Publicado: (2023)

Cost-Effectiveness of Obstructive Sleep Apnea Screening and Treatment Before Catheter Ablation for Symptomatic Atrial Fibrillation
por: Kawakami, Hiroshi, et al.
Publicado: (2020)

The Role of Animal Models in Developing Pharmacotherapy for Obstructive Sleep Apnea
por: Kim, Lenise Jihe, et al.
Publicado: (2019)

Effect of Pharmacist-Led Interventions on Physicians’ Prescribing for Pediatric Outpatients
por: Nguyen, Kien Trung, et al.
Publicado: (2022)

Use of blood biomarkers to screen for obstructive sleep apnea
por: Fleming, Wesley Elon, et al.
Publicado: (2018)

Screening for obstructive sleep apnea among hospital outpatients
por: Hug, Michel, et al.
Publicado: (2018)

Screening Severe Obstructive Sleep Apnea in Children with Snoring
por: Hsieh, Hui-Shan, et al.
Publicado: (2021)

Screening for obstructive sleep apnea before coronary angiography
por: Pei, Guo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rmj6pavqnbj3g4f5cnkbch74cf